WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006088784) USE OF ESTROGEN RECEPTOR-B SELECTIVE AGONISTS FOR RADIATION-OR CHEMOTHERAPY-INDUCED MUCOSISTIS AND RADIATION CYSTITIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/088784    International Application No.:    PCT/US2006/005000
Publication Date: 24.08.2006 International Filing Date: 14.02.2006
IPC:
A61K 31/415 (2006.01), A61K 31/277 (2006.01), A61K 31/47 (2006.01), A61K 31/353 (2006.01), A61P 17/16 (2006.01), A61P 13/10 (2006.01)
Applicants: WYETH [US/US]; A CORPOCATION OF THE STATE OF DELAWARE, Five Giralda Farms, Madison, New Jersey 07940 (US) (For All Designated States Except US).
JACOBSON, William [CA/US]; (US) (For US Only).
HARRIS, Heather, A. [US/US]; (US) (For US Only)
Inventors: JACOBSON, William; (US).
HARRIS, Heather, A.; (US)
Agent: STRAHER, Michael, P.; COZEN O'CONNOR, 1900 Market Street, Philadelphia, Pennsylvania 19103 (US)
Priority Data:
60/653,376 16.02.2005 US
Title (EN) USE OF ESTROGEN RECEPTOR-B SELECTIVE AGONISTS FOR RADIATION-OR CHEMOTHERAPY-INDUCED MUCOSISTIS AND RADIATION CYSTITIS
(FR) UTILISATION D'AGONISTES SELECTIFS DU RECEPTEUR $G(B) DES OESTROGENES DANS LE TRAITEMENT DE LA MUCOSITE INDUITE PAR DES RAYONNEMENTS OU PAR LA CHIMIOTHERAPIE ET DE LA CYSTITE RADIQUE
Abstract: front page image
(EN)The present invention provides a method of treating or inhibiting mucositis or radiation cystitis using an ER&bgr; selective ligand. The present invention also provides compositions, including pharmaceutical compositions, containing the ER&bgr; selective ligand and a traditional medicament for mucositis or radiation cystitis.
(FR)L'invention concerne une méthode de traitement ou d'inhibition de la mucosite ou de la cystite radique au moyen d'un ligand sélectif de l'ERß. L'invention concerne également des compositions, notamment des compositions pharmaceutiques, contenant ce ligand sélectif de l'ERß et un médicament traditionnel contre la mucosite ou la cystite radique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)